Identification of molecular apocrine breast tumours by microarray analysis
- PMID: 15897907
- DOI: 10.1038/sj.onc.1208561
Identification of molecular apocrine breast tumours by microarray analysis
Abstract
Previous microarray studies on breast cancer identified multiple tumour classes, of which the most prominent, named luminal and basal, differ in expression of the oestrogen receptor alpha gene (ER). We report here the identification of a group of breast tumours with increased androgen signalling and a 'molecular apocrine' gene expression profile. Tumour samples from 49 patients with large operable or locally advanced breast cancers were tested on Affymetrix U133A gene expression microarrays. Principal components analysis and hierarchical clustering split the tumours into three groups: basal, luminal and a group we call molecular apocrine. All of the molecular apocrine tumours have strong apocrine features on histological examination (P=0.0002). The molecular apocrine group is androgen receptor (AR) positive and contains all of the ER-negative tumours outside the basal group. Kolmogorov-Smirnov testing indicates that oestrogen signalling is most active in the luminal group, and androgen signalling is most active in the molecular apocrine group. ERBB2 amplification is commoner in the molecular apocrine than the other groups. Genes that best split the three groups were identified by Wilcoxon test. Correlation of the average expression profile of these genes in our data with the expression profile of individual tumours in four published breast cancer studies suggest that molecular apocrine tumours represent 8-14% of tumours in these studies. Our data show that it is possible with microarray data to divide mammary tumour cells into three groups based on steroid receptor activity: luminal (ER+ AR+), basal (ER- AR-) and molecular apocrine (ER- AR+).
Similar articles
-
Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.J Clin Pathol. 2012 Jan;65(1):64-8. doi: 10.1136/jclinpath-2011-200318. Epub 2011 Oct 29. J Clin Pathol. 2012. PMID: 22039288
-
The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours.J Pathol. 2016 Nov;240(3):256-261. doi: 10.1002/path.4772. Epub 2016 Sep 29. J Pathol. 2016. PMID: 27447842
-
New insights into the role of androgen and oestrogen receptors in molecular apocrine breast tumours.Breast Cancer Res. 2011;13(6):318. doi: 10.1186/bcr3036. Epub 2011 Dec 8. Breast Cancer Res. 2011. PMID: 22188611 Free PMC article.
-
Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast.J Clin Pathol. 2019 Jan;72(1):7-11. doi: 10.1136/jclinpath-2018-205485. Epub 2018 Nov 13. J Clin Pathol. 2019. PMID: 30425121 Review.
-
An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.Clin Breast Cancer. 2022 Jun;22(4):e576-e585. doi: 10.1016/j.clbc.2021.12.009. Epub 2021 Dec 27. Clin Breast Cancer. 2022. PMID: 35027319 Review.
Cited by
-
Using Frequent Co-expression Network to Identify Gene Clusters for Breast Cancer Prognosis.Proc Int Joint Conf Bioinforma Syst Biol Intell Comput. 2009 Aug 3:428-434. doi: 10.1109/IJCBS.2009.29. Proc Int Joint Conf Bioinforma Syst Biol Intell Comput. 2009. PMID: 23615925 Free PMC article.
-
Keratin expression in breast cancers.Virchows Arch. 2012 Sep;461(3):313-22. doi: 10.1007/s00428-012-1289-9. Epub 2012 Aug 1. Virchows Arch. 2012. PMID: 22851038
-
An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity.Cell Adh Migr. 2012 May-Jun;6(3):236-48. doi: 10.4161/cam.20880. Epub 2012 May 1. Cell Adh Migr. 2012. PMID: 22863741 Free PMC article. Review.
-
Targeting the androgen receptor in breast cancer.Curr Oncol Rep. 2015 Feb;17(2):4. doi: 10.1007/s11912-014-0427-8. Curr Oncol Rep. 2015. PMID: 25665553 Review.
-
Emerging understanding of multiscale tumor heterogeneity.Front Oncol. 2014 Dec 18;4:366. doi: 10.3389/fonc.2014.00366. eCollection 2014. Front Oncol. 2014. PMID: 25566504 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous